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Abstract
Population ageing, which has come about through the combination of increases in life expectancy, larger post-war cohorts
reaching older age and reductions in fertility, is challenging societies and particularly health and care providers, worldwide.
In Europe, the USA and Japan, there have been increases in years spent with disability and dependency. The majority of
such research, as well as professional health and social care practice, measures loss of functional capability or need for social
care, by aggregate disability scores, based around activities of daily living and instrumental activities of daily living. Although
useful for deﬁning whether an individual has passed a threshold, aggregate scores obscure how functional decline unfolds,
and therefore where early intervention might improve intrinsic capacity and reverse or slow down decline, or maintain func-
tion. We propose a framework, the compression of functional decline (CFD), based on the latest understanding of the hier-
archy of age-related functional decline, which has the potential to (i) help people understand how to live better for longer,
(ii) allow the various stakeholders to be able to measure, at a population level, whether that is happening and (iii) identify
which interventions are most effective at which stages. CFD is coherent with the World Health Organisation’s Healthy
Ageing model and is more easily understood by stakeholders and older people themselves, than current indicators such as
frailty. CFD thus provides a realistic view of age-related functional decline in the context of modiﬁable behaviour to counter
widespread public misconceptions about ageing and inform improvements.
Keywords: disability, function, disablement process, health ageing, older people
Introduction
The world’s population is ageing, with the fastest growing
section being those aged 80 years and over. In 1950 those
≥80 years comprised 7% of those aged 60 years and over,
rising to 14% by 2013. Projections suggest that this propor-
tion will rise further to 19% by 2050 and 28% by 2100 [1].
Moreover by 2050, there will be over twice as many people
aged 80 and over in less developed countries compared
with more developed ones, due to the faster population
ageing taking place in the former. In many cases, this will
mean an increase in the prevalence of chronic diseases, for
which age is the over-riding risk factor. Nevertheless,
population ageing does not necessarily result in greater preva-
lence of all diseases, and there is evidence from a number of
countries that the prevalence and incidence of dementia and
the years spent with cognitive impairment have reduced in
the recent past, even though absolute numbers with these
conditions have still increased [2, 3].
The relationship between morbidity and longevity was
debated over 30 years ago and three theories emerged:
compression of morbidity (COM) [4], expansion of mor-
bidity (EOM) [5] and dynamic equilibrium (DE) [6]. If
morbidity is deﬁned in terms of major disease, most evi-
dence points towards an EOM [7], with the interesting
exception of cognitive impairment or dementia which
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shows a COM, the number of years with cognitive impair-
ment having declined signiﬁcantly between 1990 and 2011,
at least for women [8]. These theories have fuelled the
growing emphasis from extending length of life to maximis-
ing healthy years, or ‘health span’, the latter term now
widely adopted by the biomedical community. Nevertheless,
measuring ageing with a view to optimising ‘healthy ageing’
has been approached in many ways. Most recently, the
World Health Organization has reﬂected the importance of
functional ability by deﬁning healthy ageing as ‘the process
of developing and maintaining the functional ability that
enables well-being in old age’ [9]. Indeed disability and
dependency are feared most by older people, even more than
death itself [10]. Moreover, at a population level, a number of
countries are experiencing an expansion of disability and
dependency [8, 11], though, with the increasing numbers of
very old people, the picture may be becoming more complex,
with compression and expansion existing in the same popula-
tion but for different age-groups [12]. Therefore, understand-
ing how age-related functional ability declines at an individual
and a population level, and when and where to intervene to
achieve compression, is important for both policy-makers and
older people, to plan for and shape the future.
The hierarchy of functional decline and
compression
Over the subsequent half-century since the ﬁrst develop-
ment of activities of daily living (ADL) and instrumental
activities of daily living (IADL) [13, 14], a variety of disabil-
ity scales have been developed, including the Barthel scale
[15] and the Groningen Activity Restriction Scale (GARS)
[16]. These scales are used in research as well as clinical and
professional practice, and most involving summing the
number of activities/scores requiring help or that can only
be performed with difﬁculty. Since early declines in function
need not lead to the complete loss of an ADL/IADL, later
developments have shown that it can also be important to
take account of behavioural adaptations, for example taking
more time to do a task or doing it less frequently, though
recent research suggests that these adaptations do not
always precede difﬁculty [17]. Issues with any scale that
simply sums activities to form an overall disability score are
that it (i) suppresses valuable information on the order and
timing in which individual activity loss accumulates, (ii)
does not identify the speciﬁc ADL/IADL deﬁcits and (iii)
sometimes includes only a small number of ADL/IADL,
thereby reducing its sensitivity. Underlying causes of decline
such as injury, disease and sarcopenia are associated with
varying combinations of lower and upper body strength,
balance, ﬂexibility and manual dexterity, which can often be
determined from the speciﬁc ADL/IADL. Thus, a simple
score may obscure the appropriate interventions.
In fact, ADL/IADL appear to be lost in a particular
order and this has been demonstrated by a number of
cross-sectional and longitudinal studies, and across different
age-groups, genders and populations [18–21]. Loss of
function with age that follows this pattern can be described
as ‘age-related’ to distinguish it from other patterns of pro-
gressive disability which are driven by causes other than
age. This distinction is important since disability arising
from other causes may follow very different patterns and
require different approaches to intervention. A signiﬁcant
advantage of identifying an age-related hierarchy of loss is
that it supports the design of services targeted at the stages
of progress of disability, rather than at speciﬁc ages. The
wide range of age at disability onset has been demonstrated
with studies in Australian women (mean age at disability
onset 79 years, range 45–88 years) [22], and in a British
birth cohort where functional decline occurred as early as
43 years [21]. Given that individuals vary greatly in the time
course of their ageing, the targeting of different stages in
the hierarchy is likely to be both more successful and more
cost-effective, as well as less ageist.
As longitudinal studies matured and accrued longer, and
sometimes more frequent, follow-up, researchers heeded the
call to better understand the progression of disability through
the characterisation of trajectories [23]. Such trajectories,
using summed disability scores, show remarkable similarities
in terms of substantial numbers who either remain disability-
free or experience catastrophic decline in function close to
death [24, 25]. However, few have indicated timings, and
none in a manner that could be used to target interventions.
We propose representing trajectories in terms of the
hierarchy of loss of activities with the time between stages
(Figure 1) and we call this the compression of functional
decline (CFD). Thus in Figure 1, rather than a composite
disability score on the vertical axis, we have the individual
activities in their hierarchical order of loss. The trajectory,
therefore, represents the stages through which an individual
goes as they progress through the disablement process
encountering difﬁculty with, or inability to perform inde-
pendently, each activity. In this framework, different dis-
eases or health behaviours may impact at different stages,
thereby leading to different trajectories, and there is evi-
dence that better healthy behaviours can compress disability
under certain conditions and potentially result in more rect-
angular trajectories [26]. We believe that strategies to com-
press the declines in ADL/IADL into the shortest possible
period will help to focus policy on improving health span
beyond the management of disease. CFD thus serves as a
framework: (i) for quantifying decline and (ii) as a basis for
a measurable and targeted strategy for prevention and early
intervention that would engage individuals and their fam-
ilies as well as informing a wider group of stakeholders.
Our experience to date shows it to be well understood by
older adults, by their families and practitioners, and by busi-
nesses and policy-makers.
Intervening to compress functional decline
The conceptual approach to intervening optimally to arrest
functional decline is, we suggest, in the following four
stages which should be undertaken in the given order:
New horizons in the compression of functional decline
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• Protection against decline: Loss of muscle mass and function
(sarcopenia) with age appears to be fairly consistent at
approximately 1–2% per year past the age of 50 [27].
Although a number of studies have shown that decline in
muscle strength with ageing contributes to functional lim-
itations [28], muscle power declines earlier and more rap-
idly than strength, and, at least lower extremity muscle
power, is a stronger predictor of functional performance
at older ages than muscle strength [29]. There is emerging
evidence that structured exercise of the correct type may
delay the point at which functional loss occurs [30, 31].
The US National Institute on Aging further identiﬁes bal-
ance and ﬂexibility in their four necessary elements of
exercise on its ‘Go4Life’ website: endurance, strength, bal-
ance and ﬂexibility [32]. As the science is further devel-
oped we may be able to target better interventions to
protect against decline.
• Re-activation: Recovering an ability such as walking 400 yds.
Again, randomised controlled trial (RCT) has shown that tar-
geted exercise can maintain this ability for longer, with no
signiﬁcant impact on mortality, thus suggesting that life
expectancy free of mobility limitations may be increased [33].
• Compensatory technology: Regaining a lost ADL/IADL cap-
ability through the use of a minimally compensatory tech-
nology (e.g. a walking stick restoring the ability to walk).
This is appropriate when an ADL/IADL ability is eventu-
ally lost (unavoidably or through a choice not to engage in
re-activation). Assistive technology and home modiﬁcation
have been shown to reduce further functional decline in
older adults with a disability [34], and to reduce the cost
of care required by 3.8 hours per week [35].
• Personal support: Someone else undertakes the task for the
older person (this indicates a loss of the ability, or replace-
ment of a person’s own ability). This might be necessary
at the most severe end of the hierarchy of loss of ability,
but there are compelling reasons in the ‘use it or lose it’
vein to delay this stage for as long as possible, since even
short-term muscle disuse accumulated over a period of
time may contribute to the development of sarcopenia
[36, 37]. Although this stage will not arrest further decline,
it is important to include to demonstrate that earlier inter-
ventions might minimise the time in this stage.
Beneﬁts of CFD
The future will see higher absolute numbers of older peo-
ple, and they will constitute a greater percentage of the
population. Many societies are already seeing health and
social care systems struggling to cope with their ageing
populations. If the future sees further increases in years
with high levels of dependency and poor levels of health,
societies will face additional major—yet potentially avoid-
able challenges. The aim for ‘healthy ageing’ (or ageing well)
is a good one at many levels, but the vision must be wider
than the absence of disease and chronic conditions—it
must include reduced time with functional loss i.e. com-
pressed functional decline, allowing all the associated bene-
ﬁts of a more engaged and active older population. To
achieve this, it must also drive changes in attitudes and indi-
vidual behaviour, given their impact on trajectories [38].
Early intervention and prevention of decline is a sound
idea, but how do we measure that in order to justify neces-
sary investments, and how do we know we are not simply
extending poor quality life? Given it is signiﬁcantly affected
by lifestyle choices, how do we communicate those choices
to people, and then demonstrate what works, and what effect
an individual’s choices are making? The gold standard of
RCTs for evidence is both expensive, and arguably difﬁcult
65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81
H
igh
<--
A
D
L/IA
D
L capability
--->
low
 
Age
Trajectory 1 Trajectory 2 Ideal
Figure 1. Hypothetical model of CFD where the goal is to shift trajectory 1 toward the ideal, resulting in trajectory 2 where high-
er levels of capability are maintained for longer but without adding signiﬁcantly to life expectancy. (ADL/IADL capability is represented
by individual activities in the order in which they are lost. The lowest point on the Y-axis is the point at which all 15 essential
ADL/IADL are lost and dependency is reached.)
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to achieve in the community at the required scale—with sig-
niﬁcant ethical challenges for creating control groups—but
we do need evidence. How can that be demonstrated?
CFD is an attempt to bring together evidence relating to
how people functionally decline with age and time, into a
simple framework that is understood and can be actioned
by a wide range of stakeholders. This is complemented by
an ordered, evidence-based intervention structure of delay,
reactivate, compensate and then support with care. We have
shown that there is good evidence that trajectories start at
highly variable ages, and vary widely thereafter, but that
they are also amenable to interventions [26]. Thus CFD
will work both at the individual and population level.
While the evidence for how different (but statistically com-
parable) trajectories is at an early stage, we believe our CFD
framework offers the basis for a new and useful dialogue
around ageing well, among a wide range of stakeholders.
Further, we suggest that as the measurement and understand-
ing of trajectories grows, along with what can modify them,
and the associated monetary, social and other costs, the CFD
framework will provide a useful tool for innovators to assess
and demonstrate their potential impact. By informing and
shaping a compressed period of decline, the future could be
one of more actively engaged older people for much longer,
higher levels of quality of life, and signiﬁcantly reduced health
and social care and other costs for all stakeholders.
Key points
• The majority of research and practice measures functional
decline by aggregate scores of activities of daily living.
• Aggregate disability scores obscure how decline progresses.
• We propose using the times between the hierarchy of
activity loss to better quantify how to compress functional
decline (CFD).
• CFD offers a framework for understanding the malleabil-
ity of ageing in a way accessible to a wide audience includ-
ing the public.
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